as per attachment.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sharma East India Hospitals & Medical Research Ltd reported Q1 FY26 standalone results. Revenue from Operations rose to ₹908.39 lakhs from ₹638.27 lakhs in Q1 FY25, a growth of about 42%. Total Revenue (including other income of ₹42.98 lakhs) stood at ₹951.37 lakhs. Profit for the quarter came in at roughly ₹31.80 lakhs versus ₹25.12 lakhs a year earlier, with EPS of ₹0.97 compared to ₹0.77. Total expenses were ₹947.37 lakhs. The statutory auditors, Gopal Sharma & Co., issued an unqualified limited review report with no qualifications or emphasis of matter. The board approved the results at its meeting on 8 August 2025.
Strong year-on-year topline growth and a healthy rise in profit per share signal improving operating momentum for this small-cap hospital company, which could be viewed positively by retail investors tracking earnings trajectory.